2.15pm – 3pm BST, 16 October 2024 ‐ 45 mins
Innovation showcase
Come and hear from 5 of the most exciting organisations working in this space as they walk us through their achievements, and how they will change the landscape. Vote for the one you think will have the greatest impact to give them a chance to speak again in the final plenary session.
CEO & co-Founder, Coding Bio
Dr. Simon Bornschein is the co-founder and CEO of Coding Bio, a startup advancing immunotherapies by combining high throughput screening and machine learning. With a PhD in cancer immunology from the University of Leuven, Simon previously developed CAR therapies at Celyad and Quell Therapeutics, focusing on oncology and autoinflammatory diseases.
CEO, Nanograb
Debesh is a founder and the CEO of Nanograb. Debesh's expertise lies in the implementation of molecular simulations having completed a PhD at Imperial College in simulating controlled drug delivery systems. In previous roles, he was the first software hire at the industrial biotech company FabricNano. He founded Nanograb along with PhD supervisor Stefano Angioletti-Uberti, Christopher Lau, Shanil Panara and Dame Professor Molly Stevens in 2023, spinning out from Imperial. Debesh has led the company through successful initial financing and has managed the development of Nanograb's platform that generates the best combination of binders for targeted drug delivery, taking advantage of recent advances in AI for biomolecular modelling as well as bespoke molecular simulations. The company now has an office and lab in Notting Hill, in West London and develops targeted gene delivery vectors.
Co-Founder & CEO, PentaBind
An experienced MedTech entrepreneur (3X founder; 1 Exit), Rory co-founded PentaBind in November 2021 with Phil Haynes (Drug Research) and Miguel Gonzalez (AI and Data Science). Before this Rory founded a VC-backed aptamer diagnostics company which he ran for 6 years, including 3 years in Shenzhen, China and then exited. Rory also founded Valatoa.com, a software offering exit strategy advice and business valuations to private equity. 9 years in the aptamer industry, inventor of 2 patents and past advisor for a health policy think tank, Rory also holds Master’s degrees in Entrepreneurship, Innovation & Management (Imperial College) and Engineering (University of Leeds).
CEO & Co-Founder, Tailor.Bio
Jason Yip is CEO and Co-Founder of Tailor Bio, a pioneering startup that's redefining precision medicine for deadly cancers. Tailor Bio's innovative technology decodes Chromosomal Instability (CIN), a genomic phenomenon found in 80% of cancers, yet often overlooked by current precision oncology approaches. By leveraging cutting-edge computational and AI-enabled techniques, Tailor Bio is pushing the frontiers of precision medicine to create new possibilities for patients in need.